# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATIONDECISION SUMMARYASSAY AND INSTRUMENT

I Background Information:

Arkray, Inc.

# C Proprietary and Established Names

Assure Titanium Blood Glucose Monitoring System

D Regulatory Information

<table><tr><td rowspan=1 colspan=1>ProductCode(s)</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>RegulationSection</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>PZI</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.1345 -Glucose Test System</td><td rowspan=1 colspan=1>CH - ClinicalChemistry</td></tr></table>

# II Submission/Device Overview:

# A Purpose for Submission:

This submission is a Dual 510(k) and CLIA Waiver by Application (Dual Submission) for a new device, tracked as k200788 and CW200005.

# B Measurand:

Glucose in fresh capillary whole blood drawn from the fingertips

# C Type of Test:

Quantitative amperometric assay (glucose oxidase)

# III Intended Use/Indications for Use:

A Intended Use(s):

See Indications for Use below.

# B Indication(s) for Use:

The Assure Titanium Blood Glucose Monitoring System consists of the Assure Titanium Blood Glucose meter and the Assure Titanium Blood Glucose test strips. The Assure Titanium Blood Glucose Monitoring System is intended for use in the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertips. The system is intended for in vitro diagnostic, point of care use in endocrinology clinics and nursing or skilled nursing facilities, for multiple patient use. This system should only be used with single-use, autodisabling lancing devices for drawing finger stick capillary blood.

The system is not intended for the screening or diagnosis of diabetes mellitus but is indicated for use in determining dysglycemia.

The system is not intended for use in acute care or hospital settings.

The system is not intended for neonatal use.

The system is for prescription use only.

# C Special Conditions for Use Statement(s):

Rx - For Prescription Use Only

For point-of-care use only.

In vitro diagnostic use.

Not for Alternative Site Testing (AST).

Do not use the Assure Titanium Blood Glucose Monitoring System for screening or diagnosis of diabetes.

Not indicated for use in patients undergoing tight glycemic control.

Do not use the Assure Titanium Blood Glucose Monitoring System to test neonates. The Assure Titanium Blood Glucose Monitoring System has not been validated for neonatal use.

Do not use at altitudes higher than 10,000 ft $( 3 0 4 8 ~ \mathrm { m } )$ above sea level.

Use only Assure Titanium Blood Glucose Test Strips for testing with the Assure Titanium Blood Glucose Meter.

Assure Titanium device should not be used in patients receiving intensive medical intervention/ therapy because of the potential for pre-analytical collection error and specifically in patients with decreased peripheral blood flow, as it may not reflect the true physiological state when test results are generated using capillary whole blood samples. Examples include, but are not limited to, severe hypotension, shock, hyperosmolar-hyperglycemia (with or without ketosis) and severe dehydration.

# D Special Instrument Requirements:

Assure Titanium Blood Glucose Meter

# IV Device/System Characteristics:

# A Device Description:

The Assure Titanium Blood Glucose Monitoring System consists of a battery-powered Assure Titanium Blood Glucose meter, disposable single-use Assure Titanium Blood Glucose Test Strips, Assure Control-Control Solutions (Level 1, 2 and Level 3), Quick Reference Guide and User Manual. Assure Titanium Blood Glucose Test Strips and Assure Control-Control Solutions are not included in the kit package and should be purchased separately. The candidate test strips were previously cleared in k170064 as part of the GLUCOCARD W Blood Glucose Monitoring System.

# B Principle of Operation:

The Assure Titanium Blood Glucose Monitoring System measures the amount of glucose in capillary whole blood from the fingertip quantitatively, using amperometric technology. The test is based on the measurement of the electric current generated by the reaction of the capillary whole blood glucose with glucose oxidase (GOD) and a mediator on the test strip (hexaammineruthenium (III) chloride). The magnitude of the resultant current is proportional to the glucose concentration in the sample. The detected current signal is then calculated by the meter and glucose concentration reading is then displayed on the meter.

# Instrument Description Information:

1. Instrument Name:

Assure Titanium Blood Glucose Meter

2. Specimen Identification:

There is no sample identification function with this device. Samples are applied directly to the test strip as they are collected.

3. Specimen Sampling and Handling:

The system is intended to be used with capillary whole blood from the finger only. The whole blood sample is applied directly to the test strip by capillary action.

4. Calibration:

The meter does not require calibration or coding by the user. The detection of the calibration code is automatic.

5. Quality Control:

The Assure Control - Control Solutions are aqueous solutions available at three different glucose levels (Level 1: $4 0 \mathrm { m g / L } \pm 1 1 \%$ glucose, Level 2: $: 1 3 0 \mathrm { m g / L } \pm 1 1 \%$ glucose, and Level 3 $: 3 6 0 \mathrm { m g / d L } \pm 1 1 \%$ glucose). Instructions on how to order control solutions, and when to perform a control solution test are included in the labeling. The acceptable range for each control level is printed on the test strip bottle or on the bottom of the test strip box. The meter automatically recognizes and flags the test result in the memory as a control solution test result. The user is cautioned not to use the meter and to contact the customer support if the control result falls outside the ranges printed on the test strip vial label.

# V Substantial Equivalence Information:

A Predicate Device Name(s): Statstrip Glucose Hospital Meter System B Predicate 510(k) Number(s): k132121 C Comparison with Predicate(s):

<table><tr><td colspan="1" rowspan="1">Device &amp; PredicateDevice(s):</td><td colspan="1" rowspan="1">k200788</td><td colspan="1" rowspan="1">k132121</td></tr><tr><td colspan="1" rowspan="1">Device Trade Name</td><td colspan="1" rowspan="1">Assure Titanium BloodGlucose MonitoringSystem</td><td colspan="1" rowspan="1">Statstrip GlucoseHospital Meter System</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristic Similarities</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Intended Use/IndicationsFor Use</td><td colspan="1" rowspan="1">Quantitativemeasurement of glucosein fresh capillary wholeblood samples drawnfrom the fingertips. Thesystem is intended forin vitro diagnostic,point of care, multiplepatient use inendocrinology clinicsand nursing or skillednursing facilities, as anaid to measure glucosein the blood.</td><td colspan="1" rowspan="1">Quantitativedetermination ofglucose in capillaryfinger stick, venouswhole blood, arterialwhole blood, neonatearterial whole blood andneonate heel stickspecimens. Also for thequantitativedetermination ofglucose in venouswhole blood, arterialwhole blood, neonatalheel stick, and neonatalarterial whole bloodthroughout all hospital</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">and all professionalhealthcare settings.</td></tr><tr><td colspan="1" rowspan="1">Test Principle</td><td colspan="1" rowspan="1">Electro-chemicalbiosensor(Amperometric)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Enzyme</td><td colspan="1" rowspan="1">Glucose oxidase</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Measuring Range</td><td colspan="1" rowspan="1">10-600 mg/dL</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Calibration</td><td colspan="1" rowspan="1">Automated codedcalibration</td><td colspan="1" rowspan="1">Sane</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristic Differences</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Sample Type</td><td colspan="1" rowspan="1">Fresh capillary wholeblood</td><td colspan="1" rowspan="1">Whole Blood:Capillary, Venous,Arterial, and Neonatearterial whole blood</td></tr><tr><td colspan="1" rowspan="1">Test Strip Ejector</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">No</td></tr><tr><td colspan="1" rowspan="1">Controls</td><td colspan="1" rowspan="1">2 levels of AssureControl Solutions</td><td colspan="1" rowspan="1">3 levels of NovaStatStrip ControlSolutions</td></tr><tr><td colspan="1" rowspan="1">Sample Volume</td><td colspan="1" rowspan="1">0.5 μL</td><td colspan="1" rowspan="1">1.2 μL</td></tr><tr><td colspan="1" rowspan="1">Operating Conditions</td><td colspan="1" rowspan="1">46-104 °F (8-40 °C) /10-90% RH</td><td colspan="1" rowspan="1">59-104 °F (15-40 C) /10-90% RH</td></tr><tr><td colspan="1" rowspan="1">Hematocrit Range</td><td colspan="1" rowspan="1">10-70 %</td><td colspan="1" rowspan="1">20-65 %</td></tr><tr><td colspan="1" rowspan="1">Measuring Time</td><td colspan="1" rowspan="1">7 seconds</td><td colspan="1" rowspan="1">6 seconds</td></tr></table>

# VI Standards/Guidance Documents Referenced:

IEC 60601-1-2: 2014, Medical electrical equipment - Part 1-2: General requirements for safety - Collateral Standard: Electromagnetic compatibility - Requirements and tests.

CLSI EP06-A: 2003, Evaluation of the linearity of quantitative analytical Methods: A Statistical Approach.

CLSI EP07-A2: 2005, Interference Testing in Clinical Chemistry, Approved Guideline, 2nd Edition.

CLSI EP25-A: 2009, Evaluation of stability of in vitro diagnostic reagents.

# A Analytical Performance:

# 1. Precision/Reproducibility:

Within-run and intermediate precision for the Assure Titanium Blood Glucose Monitoring System were evaluated to assess imprecision of the system across the glucose measuring range and under normal use conditions.

Within-run precision was evaluated using venous whole blood spiked with high concentration glucose solution or allowed to glycolyze to achieve 5 glucose concentrations (30-50, 51-110, 111-150, 151-250 and $2 5 0 { - } 4 0 0 ~ \mathrm { m g / d L }$ ). Each level was tested with three lots of test strips in replicates of 10 on each of 10 meters for a total of 300 results per glucose concentration and 1500 results total. Results for the within-run precision testing are summarized in the table below.

<table><tr><td rowspan=1 colspan=1>Glucose Level(mg/dL)</td><td rowspan=1 colspan=1>Lot</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean (mg/dL)</td><td rowspan=1 colspan=1>SD (mg/dL)</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=4 colspan=1>30-50</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>45.7</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>2.6%</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>44.4</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>2.9%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>42.6</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>2.4%</td></tr><tr><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>44.2</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>3.9%</td></tr><tr><td rowspan=4 colspan=1>51-110</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>96.3</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>2.1%</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>95.7</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>2.1%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>92.8</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>2.4%</td></tr><tr><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>94.9</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>2.7%</td></tr><tr><td rowspan=4 colspan=1>111-150</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>140.2</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>2.2%</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>137.8</td><td rowspan=1 colspan=1>2.8</td><td rowspan=1 colspan=1>2.0%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>139.6</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>2.3%</td></tr><tr><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>139.2</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>2.3%</td></tr><tr><td rowspan=4 colspan=1>151-250</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>203.7</td><td rowspan=1 colspan=1>6.2</td><td rowspan=1 colspan=1>3.1%</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>202.7</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>1.9%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>204.9</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>2.4%</td></tr><tr><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>203.8</td><td rowspan=1 colspan=1>5.1</td><td rowspan=1 colspan=1>2.5%</td></tr><tr><td rowspan=4 colspan=1>251-400</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>324.3</td><td rowspan=1 colspan=1>10.1</td><td rowspan=1 colspan=1>3.1%</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>324.2</td><td rowspan=1 colspan=1>7.5</td><td rowspan=1 colspan=1>2.3%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>324.1</td><td rowspan=1 colspan=1>8.7</td><td rowspan=1 colspan=1>2.7%</td></tr><tr><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>342.2</td><td rowspan=1 colspan=1>8.8</td><td rowspan=1 colspan=1>2.7%</td></tr></table>

Intermediate precision was evaluated using 5 control solutions at glucose levels within the ranges of 30-50, 51-100, 111-150, 151-250, and $2 5 1 { \mathrm { - } } 4 0 0 \ \mathrm { m g / d L }$ . Multiple operators tested the control solutions over 10 days using 3 lots of test strips and 10 meters, conducting one measurement per meter per day at the different glucose ranges. This resulted in 50 tests per lot per day for a total of 1500 tests. Results for intermediate precision testing are summarized in the table below.

<table><tr><td rowspan=1 colspan=1>Glucose Level(mg/dL)</td><td rowspan=1 colspan=1>Lot</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean (mg/dL)</td><td rowspan=1 colspan=1>SD (mg/dL)</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=4 colspan=1>30-50</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>42.8</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>1.9</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>42.4</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>42.0</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>1.5</td></tr><tr><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>42.4</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>1.9</td></tr><tr><td rowspan=1 colspan=1>51-110</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>87.3</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>87.4</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.2</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>86.2</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>1.7</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>87.0</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=1>111-150</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>129.8</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>1.3</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>129.7</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>1.1</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>128.5</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>1.4</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>129.3</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>1.4</td></tr><tr><td rowspan=1 colspan=1>151-250</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>256.6</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>1.3</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>255.8</td><td rowspan=1 colspan=1>3.3</td><td rowspan=1 colspan=1>1.3</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>251.8</td><td rowspan=1 colspan=1>3.5</td><td rowspan=1 colspan=1>1.4</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>254.7</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>1.5</td></tr><tr><td rowspan=1 colspan=1>251-400</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>363.9</td><td rowspan=1 colspan=1>5.3</td><td rowspan=1 colspan=1>1.5</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>364.6</td><td rowspan=1 colspan=1>5.6</td><td rowspan=1 colspan=1>1.5</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>353.4</td><td rowspan=1 colspan=1>5.5</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>360.6</td><td rowspan=1 colspan=1>7.5</td><td rowspan=1 colspan=1>2.1</td></tr></table>

2. Linearity:

Linearity of the Assure Titanium Blood Glucose Monitoring System was evaluated using venous whole blood spiked with high concentration glucose solution or allowed to glycolyze to achieve 11 glucose concentrations (6.3, 31.2, 46.9, 68.9, 135.0, 197.0, 254.5, 351.9, 421.0, 493.5 and $6 1 3 . 3 \mathrm { m g / d L }$ ). The target glucose concentrations were verified by the comparator method (YSI 2300 STAT Plus analyzer). Results on the candidate device were compared to results on the comparator. Each glucose level was tested using 3 test strip lots and 5 meters, for a total of 15 replicates per level and a total of 165 results.

Linear regression data analysis, with regression equation and coefficient of determination $( \mathbb { R } ^ { 2 } )$ presented for each lot tested is summarized in the table below:

<table><tr><td rowspan=1 colspan=1>Lot</td><td rowspan=1 colspan=1>Linear Regression Equation</td><td rowspan=1 colspan=1>$R^2</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>y=1.0079x + 3.9485</td><td rowspan=1 colspan=1>0.9988</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>y=1.0063x+ 3.3727</td><td rowspan=1 colspan=1>0.9993</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>y = 0.9902x + 2.1839</td><td rowspan=1 colspan=1>0.9999</td></tr></table>

The results of the study support linearity of the Assure Titanium Blood Glucose Monitoring System across the claimed measuring range of $\mathrm { 1 0 { - } 6 0 0 ~ m g / d L }$ . If the concentration of a sample is less than $1 0 \mathrm { m g / d L }$ glucose, the result is flagged by the meter as “Lo”. If a sample exceeds $6 0 0 \mathrm { m g / d L }$ glucose, the result is flagged by the meter as “Hi”. The “Lo” and “Hi” functions were validated and demonstrated to function as intended.

# 3. Analytical Specificity/Interference:

Interference testing was conducted to evaluate the effect of common endogenous substances and exogenous substances expected in the intended use population on the Assure Titanium Blood Glucose Monitoring System. Additional potential interferents were included in the testing following a detailed analysis of medications and medical conditions of the subjects evaluated in the method comparison study (please see the tables in Section VII.B.1 below for a detailed list of medications and conditions). The study was designed using whole blood samples spiked or allowed to glycolyze to 3 target glucose levels $\mathrm { 5 0 { - } 7 0 m g / d L }$ , 110-130 $\mathrm { m g / d L }$ , and $2 2 5 { - } 2 7 0 \ \mathrm { m g / d L }$ ). Samples were divided into a test pool with the potential interferent added and a control sample with no added interferent. Each interferent was tested at clinically relevant concentrations.

Results on the candidate meter from the test samples were compared to results obtained on the candidate meter from the control sample. If interference was observed, additional testing was performed to determine the concentration at which the interference starts to occur. Potentially interfering substances, the maximum concentrations tested and the highest tested concentration at which no significant interference (defined by the sponsor as average $\%$ bias $\leq 1 0 \% )$ was observed are listed in the table below:

<table><tr><td colspan="1" rowspan="1">PotentialInterfering Substance</td><td colspan="1" rowspan="1">Highest Concentration with no SignificantInterference</td></tr><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">20 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Ascorbic acid</td><td colspan="1" rowspan="1">4 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Conjugated Bilirubin</td><td colspan="1" rowspan="1">50 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Unconjugated Bilirubin</td><td colspan="1" rowspan="1">40 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">500 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">15 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Dopamine</td><td colspan="1" rowspan="1">20 mg/dL</td></tr><tr><td colspan="1" rowspan="1">EDTA</td><td colspan="1" rowspan="1">180 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Galactose</td><td colspan="1" rowspan="1">60 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">700 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Reduced Glutathione</td><td colspan="1" rowspan="1">92 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">20,000 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Heparin</td><td colspan="1" rowspan="1">500 IU/dL</td></tr><tr><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">50 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Icodextrin</td><td colspan="1" rowspan="1">1094.4 mg/dL</td></tr><tr><td colspan="1" rowspan="1">L-Dopa</td><td colspan="1" rowspan="1">0.75 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Maltose</td><td colspan="1" rowspan="1">5,000 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Methyl-L-dopa</td><td colspan="1" rowspan="1">1000 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Salicylic acid</td><td colspan="1" rowspan="1">60 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Sodium</td><td colspan="1" rowspan="1">414 mmol/L</td></tr><tr><td colspan="1" rowspan="1">Tolbutamide</td><td colspan="1" rowspan="1">100 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Tolazamide</td><td colspan="1" rowspan="1">40 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Triglycerides</td><td colspan="1" rowspan="1">1,500 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Uric acid</td><td colspan="1" rowspan="1">24 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Xylose</td><td colspan="1" rowspan="1">300 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Xylitol</td><td colspan="1" rowspan="1">0.09 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Mannitol</td><td colspan="1" rowspan="1">1,800 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Fenofibric Acid</td><td colspan="1" rowspan="1">18 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Canagliflozin</td><td colspan="1" rowspan="1">15 x 10-4 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Amlodipine Besylate</td><td colspan="1" rowspan="1">18 x 10-4 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Atorvastatin Calcium</td><td colspan="1" rowspan="1">84 x 10-4 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Cilostazol</td><td colspan="1" rowspan="1">21 x 10-2 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Prasugrel</td><td colspan="1" rowspan="1">105 x 10-3 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline HC1</td><td colspan="1" rowspan="1">45 x 10-6 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Budesonide</td><td colspan="1" rowspan="1">36 x 10-5 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">9 x 10-4 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Oxcarbazepine</td><td colspan="1" rowspan="1">258 x 10-2 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Trihexyphenidyl HCL</td><td colspan="1" rowspan="1">15 x 10-3 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Fluphenazine Decanoate</td><td colspan="1" rowspan="1">81 x 10-5 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Levoflaxicin</td><td colspan="1" rowspan="1">183 x 10-5 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Glimiperide</td><td colspan="1" rowspan="1">576 x 10-4 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Benazeprilat</td><td colspan="1" rowspan="1">297 nmol/dL</td></tr><tr><td colspan="1" rowspan="1">Saxagliptin</td><td colspan="1" rowspan="1">72 x 10-4 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">28.3 nmol/dL</td></tr><tr><td colspan="1" rowspan="1">Ursodiol</td><td colspan="1" rowspan="1">7,836 x 10-4 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Silodosin</td><td colspan="1" rowspan="1">1848 x 10-5 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Letrozole</td><td colspan="1" rowspan="1">31.2 nmol/dL</td></tr></table>

The following limitations are included in the user manual and test strip package insert: • Patients with high doses of Vitamin $C$ intake (ascorbic acid; blood levels higher than 4 mg/dL) may yield inaccurate results. Patients undergoing oxygen therapy may yield inaccurate results.

4. Assay Reportable Range: The reportable range is $1 0 - 6 0 0 \mathrm { m g / d L }$ .

5. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods):

The Assure Titanium Blood Glucose Monitoring System is traceable to the NIST (SRM) 917c glucose reference material. A method comparison was performed using the candidate device and YSI 2300 STAT Plus as the comparator method (see section VII.A.3 below).

# Test Strip Stability

Shelf-life and open vial stability protocols and acceptance criteria for the Assure Titanium Blood Glucose Test Strips were previously evaluated in k170064 and were found to support the claimed shelf-life of 24 months and open vial stability of 6 months when stored at 34- $8 6 \mathrm { { ^ \circ F } }$ $( 1 - 3 0 ^ { \circ } \mathrm { C } )$ and $10 \mathrm { - } 9 0 \%$ relative humidity.

6. Detection Limit: Not applicable.

7. Assay Cut-Off: Not applicable.

8. Accuracy (Instrument): Not applicable.

9. Carry-Over: Not applicable.

# B Comparison Studies:

1. Method Comparison with Predicate Device:

The performance of the Assure Titanium Blood Glucose Monitoring System was established in the intended use environment using capillary fingerstick samples from 396 patients at three clinical sites covering the two intended use settings (one nursing and skilled nursing facility and two endocrinology clinics) across the United States using untrained intended use operators (point-of-care operators). Site 1 was a 475-bed nursing and skilled nursing site. The study took place across both the long-term care nursing and rehabilitation unit (also known as a temporary care unit). Sites 2 and 3 were endocrinology clinics.

All testing with the Assure Titanium Blood Glucose Meter was performed by CLIA waived operators (non-laboratory personnel, e.g., registered nurses/licensed practical nurses, medical aides, office manager, receptionist).

The glucose levels tested ranged from 29.0 to $4 9 2 . 5 \mathrm { m g / L }$ , with 32 results falling below 80 $\mathrm { m g / d L }$ and 22 results falling above $3 0 0 \mathrm { m g / d L }$ . The hematocrit and sodium levels for all subjects tested were recorded. Testing was performed on six lots of Assure Titanium test strips using 26 Assure Titanium meters. The clinical study included subjects with reported 390 unique patient medical conditions receiving a total of 4066 unique medications, that accounted for 379 drugs classified by generic name, representing 14 main drug classes including nervous system, cardiovascular system, and alimentary tract and metabolism drug classes.

The Assure Titanium Blood Glucose Monitoring System results were compared to the YSI 2300 STAT Plus as the comparator method. The results were calculated separately for each type of clinical site as well as all sites combined.

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>Site Type</td><td rowspan=1 colspan=1>Number ofPatients</td><td rowspan=1 colspan=1>Glucose Range(mg/dL)</td><td rowspan=1 colspan=1>Hematocrit(%)</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Nursing and skillednursing facility</td><td rowspan=1 colspan=1>130</td><td rowspan=1 colspan=1>29.0-405.5</td><td rowspan=1 colspan=1>19-44</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>EndocrinologyClinic</td><td rowspan=1 colspan=1>165</td><td rowspan=1 colspan=1>43.7-492.5</td><td rowspan=1 colspan=1>25-51</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>EndocrinologyClinic</td><td rowspan=1 colspan=1>101</td><td rowspan=1 colspan=1>49.3-367.8</td><td rowspan=1 colspan=1>30-54</td></tr></table>

The results from the capillary fingerstick samples obtained from the Assure Titanium Blood Glucose Meter compared to the results from the comparator method, per site type, as well as all sites combined are summarized below:

Results for Glucose Concentrations $< 7 5 \ \mathrm { m g / d L }$ :   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>Within±5 mg/dL</td><td rowspan=1 colspan=1>Within±10 mg/dL</td><td rowspan=1 colspan=1>Within±12 mg/dL</td><td rowspan=1 colspan=1>Within±15 mg/dL</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1/1(100%)</td><td rowspan=1 colspan=1>1/1(100%)</td><td rowspan=1 colspan=1>1/1(100%)</td><td rowspan=1 colspan=1>1/1(100%)</td></tr><tr><td rowspan=1 colspan=1>2 and 3</td><td rowspan=1 colspan=1>17/26(65.4%)</td><td rowspan=1 colspan=1>25/26(96.2%)</td><td rowspan=1 colspan=1>26/26(100%)</td><td rowspan=1 colspan=1>26/26(100%)</td></tr><tr><td rowspan=1 colspan=1>All sitescombined</td><td rowspan=1 colspan=1>18/27(66.7%)</td><td rowspan=1 colspan=1>26/27(96.3%)</td><td rowspan=1 colspan=1>27/27(100%)</td><td rowspan=1 colspan=1>27/27(100%)</td></tr></table>

Results for Glucose Concentrations $\geq 7 5 { \mathrm { ~ m g / d L } }$ :   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>Within ±5%</td><td rowspan=1 colspan=1>Within ±10%</td><td rowspan=1 colspan=1>Within ±12%</td><td rowspan=1 colspan=1>Within ±15%</td><td rowspan=1 colspan=1>Within ±20%</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>80/129(62.0 %)</td><td rowspan=1 colspan=1>122/129(94.6%)</td><td rowspan=1 colspan=1>125/129(96.9%)</td><td rowspan=1 colspan=1>128/129(99.2%)</td><td rowspan=1 colspan=1>129/129(100%)</td></tr><tr><td rowspan=1 colspan=1>2+3</td><td rowspan=1 colspan=1>163/240(67.9%)</td><td rowspan=1 colspan=1>224/240(93.3%)</td><td rowspan=1 colspan=1>230/240(95.8%)</td><td rowspan=1 colspan=1>235/240(97.9%)</td><td rowspan=1 colspan=1>240/240(100%)</td></tr><tr><td rowspan=1 colspan=1>All sitescombined</td><td rowspan=1 colspan=1>243/369(65.9%)</td><td rowspan=1 colspan=1>346/369(93.8%)</td><td rowspan=1 colspan=1>355/369(96.2%)</td><td rowspan=1 colspan=1>363/369(98.4%)</td><td rowspan=1 colspan=1>369/369(100%)</td></tr></table>

The sponsor also conducted a usability study of the Assure Titanium Blood Glucose Monitoring System. The 10 point-of-care operators who participated in the study filled out two questionnaires: one concerning the ease of the use of the blood glucose system and one concerning the ease of understanding of the user manual and QRG. The results demonstrated that the participants were able to understand the labeling and conduct the testing on their own.

A readability assessment using SMOG analysis was conducted, and the results demonstrate that the of the user manual and quick reference guide (QRG) were written at a 7.4 and 7.2 grade level, respectively.

# Patient Conditions:

The 396 study participants fell into the following medical condition categories that included over 415 unique patient medical conditions, as described in the table below:

<table><tr><td rowspan=1 colspan=1>Condition Category</td><td rowspan=1 colspan=1>Medical Condition</td><td rowspan=1 colspan=1>Number of Patients</td></tr><tr><td rowspan=3 colspan=1>Auditory</td><td rowspan=1 colspan=1>Excessive Cerumen</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Hard of Hearing</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Ruptured Eardrum</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=4 colspan=1>Biliary</td><td rowspan=1 colspan=1>Cholangitis</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Cholecystectomy</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Cholecystitis</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Cholelithiasis</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=3 colspan=1>Cancer</td><td rowspan=1 colspan=1>Benign Neoplasm</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Bone Cancer</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Brain Cancer</td><td rowspan=1 colspan=1>1</td></tr></table>

<table><tr><td rowspan=1 colspan=2>EY</td></tr><tr><td rowspan=1 colspan=1>Medical Condition</td><td rowspan=1 colspan=1>Number of Patients</td></tr><tr><td rowspan=1 colspan=1>Breast Cancer</td><td rowspan=1 colspan=1>8</td></tr><tr><td rowspan=1 colspan=1>Breast Cancer, Historical</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Colon Cancer</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Colon Cancer, Historical</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Hepatocellular Carcinoma</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Leukemia</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Lipoma</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Liver Cancer</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Lung Cancer</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Lymphatic Cancer</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Meningioma</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Multiple Myeloma</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Non-Hodgkin&#x27;s Lymphoma</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Pancreatic Cancer</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Prostate Cancer</td><td rowspan=1 colspan=1>6</td></tr><tr><td rowspan=1 colspan=1>Renal Cancer</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Renal Cancer, Historical</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Skin Cancer</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Skin Cancer, Historical</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Throat Cancer</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Thyroid Cancer</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Thyroid Cancer, Historical</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Aortic Aneurysm</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Aortic Insufficiency</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Aortic Regurgitation</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Aortic Stenosis</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>Arrhythmia</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Arteriosclerosis</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Atrial Fibrillation</td><td rowspan=1 colspan=1>32</td></tr><tr><td rowspan=1 colspan=1>Bradycardia</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Bundle Branch Block</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Cardiovascular Disease</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Carotid Artery Occlusion</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Chest Pain</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Chronic Systolic HeartFailure</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Coronary Artery Disease</td><td rowspan=1 colspan=1>36</td></tr><tr><td rowspan=1 colspan=1>Elevated Troponin</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Endocarditis</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Heart Block</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Heart Disease</td><td rowspan=1 colspan=1>7</td></tr><tr><td rowspan=1 colspan=1>Heart Failure</td><td rowspan=1 colspan=1>41</td></tr><tr><td rowspan=1 colspan=1>Heart Murmur</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Hypertension</td><td rowspan=1 colspan=1>248</td></tr><tr><td rowspan=1 colspan=1>Hypotension</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Mitral Insufficiency</td><td rowspan=1 colspan=1>1</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Condition Category</td><td colspan="1" rowspan="1">Medical Condition</td><td colspan="1" rowspan="1">Number of Patients</td></tr><tr><td colspan="1" rowspan="17"></td><td colspan="1" rowspan="1">Mitral Regurgitation</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Mitral Stenosis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Mitral Valve Prolapse</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Myocardial Infarction</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Myocarditis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Occlusion and Stenosis ofCarotid Artery</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Palpitations</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Patent Foramen Ovale</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Premature Atrial Contraction</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Premature VentricularContractions</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Sick Sinus Syndrome</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Sinus Node Dysfunction</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Sleep Apnea</td><td colspan="1" rowspan="1">19</td></tr><tr><td colspan="1" rowspan="1">Tachycardia</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Tricuspid Regurgitation</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Ventricular Arrhythmia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Ventricular OutflowObstruction</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="19">Dermatological</td><td colspan="1" rowspan="1">Abscess</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Asteototic Dermatitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Blepharitis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Dermatitis</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">Eczema</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Erythema</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Foot Complications</td><td colspan="1" rowspan="1">39</td></tr><tr><td colspan="1" rowspan="1">Intertrigo</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Pruritic Disorder</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Pruritus</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Psoriasis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Rosacea</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Seborrheic Dermatitis</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Seborrheic Keratosis</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Skin Complications</td><td colspan="1" rowspan="1">21</td></tr><tr><td colspan="1" rowspan="1">Skin Infection</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Skin Ulcer</td><td colspan="1" rowspan="1">29</td></tr><tr><td colspan="1" rowspan="1">Tinea Pedis</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Tinea Versicolor</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="3">Endocrine</td><td colspan="1" rowspan="1">Adrenal Insufficiency</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Adrenal Nodule</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Gynecomastia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="4">Gastro-Intestinal</td><td colspan="1" rowspan="1">Acid Reflux</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Celiac Disease</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Colitis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Colon Polyp</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="21">′</td><td colspan="1" rowspan="1">Constipation</td><td colspan="1" rowspan="1">68</td></tr><tr><td colspan="1" rowspan="1">Diarrhea</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">Diverticulitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Diverticulosis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Gastroenteritis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Gastroesophageal RefluxDisease</td><td colspan="1" rowspan="1">51</td></tr><tr><td colspan="1" rowspan="1">Gastrointestinal Hemorrhage</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Gastrointestinal Problems</td><td colspan="1" rowspan="1">34</td></tr><tr><td colspan="1" rowspan="1">Heartburn</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Incontinence</td><td colspan="1" rowspan="1">26</td></tr><tr><td colspan="1" rowspan="1">Indigestion</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Irritable Bowel Syndrome</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Irritable Colon</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Ischemic Colitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Malabsorption Syndrome</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Nausea</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Pancreatitis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Peptic Ulcer</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Rectal Prolapse</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Ulcer</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Vomiting</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="11">Hepatic</td><td colspan="1" rowspan="1">Bilirubinemia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Cirrhosis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Elevated INR</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Fatty Liver</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Hepatitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hyperbilirubinemia</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Liver Dysfunction</td><td colspan="1" rowspan="1">8</td></tr><tr><td colspan="1" rowspan="1">Subtherapeutic INR</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Supratherapeutic INR</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Transaminitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hypoalbuminemia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="3">Hormonal</td><td colspan="1" rowspan="1">Hyperprolactinemia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hypogonadism</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Polycystic OvarianSyndrome</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="9">Immune</td><td colspan="1" rowspan="1">Arthritis</td><td colspan="1" rowspan="1">12</td></tr><tr><td colspan="1" rowspan="1">Bacteremia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Bacterial Infection</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Candida Infection</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Cellulitis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Cold Sores</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Crohn's</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Eosinophilia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Fever</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="24"></td><td colspan="1" rowspan="1">Gout</td><td colspan="1" rowspan="1">19</td></tr><tr><td colspan="1" rowspan="1">Herpes Zoster</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">IdiopathicThrombocytopenic Purpura</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Immunodeficiency</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Immunosuppression</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Joint Inflammation</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Leukocytosis</td><td colspan="1" rowspan="1">16</td></tr><tr><td colspan="1" rowspan="1">Leukopenia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Lichen Planus</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Lymphadenitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Lymphedema</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Myasthenia Gravis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Myelodysplastic Syndrome</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Oligoarthritis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Onychomycosis</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Paronychia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Photosensitivity</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Plantar Fasciitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Polymyalgia Rheumatica</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Rheumatoid Arthritis</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Sepsis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Septic Arthritis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Sjogrens Syndrome</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Verruca</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="2">Lipid Disorder</td><td colspan="1" rowspan="1">Dyslipidemia</td><td colspan="1" rowspan="1">11</td></tr><tr><td colspan="1" rowspan="1">Hyperlipidemia</td><td colspan="1" rowspan="1">126</td></tr><tr><td colspan="1" rowspan="19">Metabolic</td><td colspan="1" rowspan="1">Diabetic Ketoacidosis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Gestational Diabetes</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hemochromatosis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hereditary Coproporphyria</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hypercalcemia</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Hypercholesteremia</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Hypercholesterolemia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hyperglycemia</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Hyperkalemia</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Hypernatremia</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Hyperuricemia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hypocalcemia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hypoglycemia</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Hypokalemia</td><td colspan="1" rowspan="1">16</td></tr><tr><td colspan="1" rowspan="1">Hypomagnesemia</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Hyponatremia</td><td colspan="1" rowspan="1">13</td></tr><tr><td colspan="1" rowspan="1">Malnutrition</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">Microalbuminuria</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Obesity</td><td colspan="1" rowspan="1">12</td></tr><tr><td colspan="1" rowspan="4"></td><td colspan="1" rowspan="1">Tumoral Calcinosis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Vitamin Deficiency</td><td colspan="1" rowspan="1">42</td></tr><tr><td colspan="1" rowspan="1">Weight Gain</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Weight Loss</td><td colspan="1" rowspan="1">19</td></tr><tr><td colspan="1" rowspan="28">Musculoskeletal</td><td colspan="1" rowspan="1">Achalasia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Bursitis</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Cervical Spondylosis</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Contracture</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Degenerative Disc Disease</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">DegenerativeSpondylolisthesis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Dysarthria</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Dystonia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Esophageal Dysmotility</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hernia</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">Kyphosis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Leg Cramp</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Monoclonal Gammopathy ofUnknown Significance</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Muscle Spasms</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Muscle Weakness</td><td colspan="1" rowspan="1">8</td></tr><tr><td colspan="1" rowspan="1">Muscular Dystrophy</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Myalgia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Myositis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Osteoarthritis</td><td colspan="1" rowspan="1">37</td></tr><tr><td colspan="1" rowspan="1">Osteomyelitis</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Osteopenia</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Osteoporosis</td><td colspan="1" rowspan="1">24</td></tr><tr><td colspan="1" rowspan="1">Pancytopenia</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Polyarthralgia</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Scoliosis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Spinal Stenosis</td><td colspan="1" rowspan="1">16</td></tr><tr><td colspan="1" rowspan="1">Temporomandibular JointSyndrome</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Tendinitis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="11">Neurological</td><td colspan="1" rowspan="1">Agitation</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Alzheimer's</td><td colspan="1" rowspan="1">14</td></tr><tr><td colspan="1" rowspan="1">Amnesia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Anorexia</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Anxiety</td><td colspan="1" rowspan="1">27</td></tr><tr><td colspan="1" rowspan="1">Autonomic Neuropathy</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Bipolar Disorder</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Carpal Tunnel</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Cervical Radiculopathy</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Cervicalgia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Chronic Hypomanic</td><td colspan="1" rowspan="1">1</td></tr></table>

<table><tr><td rowspan=1 colspan=2>EY</td></tr><tr><td rowspan=1 colspan=1>Medical Condition</td><td rowspan=1 colspan=1>Number of Patients</td></tr><tr><td rowspan=1 colspan=1>Chronic Pain</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Claustrophobia</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Cognitive Impairment</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>Concussion</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Cord Compression</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Delirium</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Delusions</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Dementia</td><td rowspan=1 colspan=1>33</td></tr><tr><td rowspan=1 colspan=1>Depression</td><td rowspan=1 colspan=1>45</td></tr><tr><td rowspan=1 colspan=1>Diplegia</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Dizziness</td><td rowspan=1 colspan=1>6</td></tr><tr><td rowspan=1 colspan=1>Dysautonomia</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Dysphagia</td><td rowspan=1 colspan=1>27</td></tr><tr><td rowspan=1 colspan=1>Dysphonia</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Dysthymia</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Encephalopathy</td><td rowspan=1 colspan=1>12</td></tr><tr><td rowspan=1 colspan=1>Essential Tremor</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Excoriation</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Fibromyalgia</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Globus Sensation</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Hallucinations</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Headache</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Lumbar Radiculopathy</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Memory Issues</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Migraine</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Mood Disorder</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Motor Skill Impairment</td><td rowspan=1 colspan=1>11</td></tr><tr><td rowspan=1 colspan=1>Myoclonus</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Narcolepsy</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Neuralgia</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Neurologic NeglectSyndrome</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Neuropathy</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Nicotine Addiction</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Obsessive CompulsiveDisorder</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Orthostatic Hypertension</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Orthostatic Hypotension</td><td rowspan=1 colspan=1>11</td></tr><tr><td rowspan=1 colspan=1>Palsy</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Panic Attacks</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Parkinson&#x27;s</td><td rowspan=1 colspan=1>7</td></tr><tr><td rowspan=1 colspan=1>Polyneuropathy</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Post-Traumatic StressDisorder</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Postural OrthostaticTachycardia Syndrome</td><td rowspan=1 colspan=1>1</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Condition Category</td><td colspan="1" rowspan="1">Medical Condition</td><td colspan="2" rowspan="1">Number of Patients</td></tr><tr><td colspan="1" rowspan="11">−</td><td colspan="1" rowspan="1">Radicular Syndrome</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Schizophrenia</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Sciatica</td><td colspan="2" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Seizures</td><td colspan="2" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Somnolence</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Syrinx of Spinal Cord</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Tardive Dyskinesia</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Tremor</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Vascular Dementia</td><td colspan="2" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Vasovagal Syncope</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Vertigo</td><td colspan="2" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="12">Ocular</td><td colspan="1" rowspan="1">Blindness</td><td colspan="2" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Bullous Keratopathy</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Cataract</td><td colspan="2" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">Conjunctivitis</td><td colspan="2" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Dry Eye</td><td colspan="2" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">Glaucoma</td><td colspan="2" rowspan="1">22</td></tr><tr><td colspan="1" rowspan="1">Macular Degeneration</td><td colspan="2" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Macular Edema</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Pseudophakia</td><td colspan="2" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Retinopathy</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Vision Problems</td><td colspan="2" rowspan="1">78</td></tr><tr><td colspan="1" rowspan="1">Visual Impairment</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="3">Oral</td><td colspan="1" rowspan="1">Dental Abscess</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Gingival Bleeding</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Xerostomia</td><td colspan="2" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="19">Other</td><td colspan="1" rowspan="1">Abnormal Gait</td><td colspan="2" rowspan="1">26</td></tr><tr><td colspan="1" rowspan="1">Apathy</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Ascites</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Balance Issues</td><td colspan="2" rowspan="1">45</td></tr><tr><td colspan="1" rowspan="1">Debility</td><td colspan="2" rowspan="1">55</td></tr><tr><td colspan="1" rowspan="1">Dehydration</td><td colspan="2" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Fatigue</td><td colspan="2" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Frailty Syndrome</td><td colspan="2" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Hyperproteinemia</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hypothermia</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Impaired Mobility</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Insomnia</td><td colspan="2" rowspan="1">53</td></tr><tr><td colspan="1" rowspan="1">Lethargy</td><td colspan="2" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Mobility Issues</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Organ Prolapse</td><td colspan="2" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Overweight</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Polypharmacy</td><td colspan="2" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Polytrauma</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Sequela</td><td colspan="2" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Condition Category</td><td colspan="1" rowspan="1">Medical Condition</td><td colspan="1" rowspan="1">Number of Patients</td></tr><tr><td colspan="1" rowspan="1">Pancreatic</td><td colspan="1" rowspan="1">Intraductal PapillaryMucinous Neoplasm</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="14">Renal</td><td colspan="1" rowspan="1">Acute Kidney Disease</td><td colspan="1" rowspan="1">28</td></tr><tr><td colspan="1" rowspan="1">Chronic Kidney Disease</td><td colspan="1" rowspan="1">54</td></tr><tr><td colspan="1" rowspan="1">Diabetes Insipidus</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Elevated AlkalinePhosphatase</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Elevated Uric Acid</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hematuria</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">Hepatorenal Syndrome</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hyperosmolality</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Interstitial Nephritis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Kidney Disease</td><td colspan="1" rowspan="1">49</td></tr><tr><td colspan="1" rowspan="1">Nephrolithiasis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Nephropathy</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Renal Mass</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Tubulointerstitial Disease</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="5">Reproductive</td><td colspan="1" rowspan="1">Benign Prostatic Hyperplasia</td><td colspan="1" rowspan="1">17</td></tr><tr><td colspan="1" rowspan="1">Endometriosis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Enlarged Prostate</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Impotence</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="1">Prostatitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="22">Respiratory</td><td colspan="1" rowspan="1">Allergic Rhinitis</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Asthma</td><td colspan="1" rowspan="1">12</td></tr><tr><td colspan="1" rowspan="1">Bronchiectasis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Bronchitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Chronic ObstructivePulmonary Disease</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Cough</td><td colspan="1" rowspan="1">17</td></tr><tr><td colspan="1" rowspan="1">Dyspnea</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Hypercarbia</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Lung Disease</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Pickwickian Syndrome</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Pleural Effusion</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Pneumonia</td><td colspan="1" rowspan="1">13</td></tr><tr><td colspan="1" rowspan="1">Pneumonitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Pulmonary Edema</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Pulmonary Embolism</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Pulmonary Fibrosis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Pulmonary Infection</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Pulmonary MycobacterialInfection</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Pulmonary Nodules</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Respiratory Failure</td><td colspan="1" rowspan="1">9</td></tr><tr><td colspan="1" rowspan="1">Restrictive Lung Disease</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Shortness of Breath</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="2"></td><td colspan="1" rowspan="1">Sinusitis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Upper Respiratory Infection</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="9">Thyroid</td><td colspan="1" rowspan="1">Diaphoresis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Goiter</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Hashimoto's</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Hyperparathyroidism</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Hyperthyroidism</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Hypoparathyroidism</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hypothyroidism</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">Thyroid Disorder</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Thyroid Nodule</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="8">Urinary</td><td colspan="1" rowspan="1">Bacteriuria</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Bladder Diverticulus</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Cystitis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Dysuria</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Frequent Urination</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Overactive Bladder</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Urinary Retention</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">Urinary Tract Infection</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="25">Vascular</td><td colspan="1" rowspan="1">Anemia</td><td colspan="1" rowspan="1">65</td></tr><tr><td colspan="1" rowspan="1">Aneurysm</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Arterial Embolism</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Artery Stenosis</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Atherosclerosis</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Cerebral Artery Syndrome</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Cerebral MicrovascularDisease</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Cerebral Vascular Accident</td><td colspan="1" rowspan="1">9</td></tr><tr><td colspan="1" rowspan="1">Cerebrovascular Disease</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Coagulopathy</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Contusion</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Deep Vein Thrombosis</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Edema</td><td colspan="1" rowspan="1">33</td></tr><tr><td colspan="1" rowspan="1">Epistaxis</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Gangrene</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Hematoma</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Hemorrhage</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Hemorrhoids</td><td colspan="1" rowspan="1">11</td></tr><tr><td colspan="1" rowspan="1">Hypocapnia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Hypoxemia</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Hypoxia</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Ischemia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Methemoglobinemia</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Peripheral Vascular Disease</td><td colspan="1" rowspan="1">17</td></tr><tr><td colspan="1" rowspan="1">Pulmonary VascularCongestion</td><td colspan="1" rowspan="1">1</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Condition Category</td><td rowspan=1 colspan=1>Medical Condition</td><td rowspan=1 colspan=1>Number of Patients</td></tr><tr><td rowspan=12 colspan=3>−</td><td rowspan=1 colspan=1>Purpura</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Stroke</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>Swelling</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Syncope</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Thalassemia</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Thrombocytopenia</td><td rowspan=1 colspan=1>14</td></tr><tr><td rowspan=1 colspan=1>Thrombocytosis</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Thrombosis</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Transient Ischemic Attack</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Varicose Veins</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Venous Insufficiency</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Venous Ulcer</td><td rowspan=1 colspan=1>2</td></tr></table>

# Medications:

During the study, participants received a total of 4066 unique medications, that accounted for 379 drugs classified by generic name, representing multiple drug classes, as described in the table below:

<table><tr><td colspan="1" rowspan="1">Therapeutic Drug Class 2</td><td colspan="1" rowspan="1">Therapeutic Drug Class 3</td><td colspan="1" rowspan="1">Number ofPatients</td></tr><tr><td colspan="1" rowspan="2">Agents Acting on the Renin-Angiotensin System</td><td colspan="1" rowspan="1">ACE Inhibitors, Plain</td><td colspan="1" rowspan="1">107</td></tr><tr><td colspan="1" rowspan="1">Angiotensin II Receptor Blockers(ARBs), Plain</td><td colspan="1" rowspan="1">62</td></tr><tr><td colspan="1" rowspan="1">Agents Acting on the Renin-Angiotensin System</td><td colspan="1" rowspan="1">Angiotensin II Receptor Blockers(ARBs), Combinations</td><td colspan="1" rowspan="1">11</td></tr><tr><td colspan="1" rowspan="1">All Other Therapeutic Products</td><td colspan="1" rowspan="1">All Other Therapeutic Products</td><td colspan="1" rowspan="1">13</td></tr><tr><td colspan="1" rowspan="1">Anabolic Agents for Systemic Use</td><td colspan="1" rowspan="1">Other Mineral Supplements</td><td colspan="1" rowspan="1">29</td></tr><tr><td colspan="1" rowspan="2">Analgesics</td><td colspan="1" rowspan="1">Opioids</td><td colspan="1" rowspan="1">66</td></tr><tr><td colspan="1" rowspan="1">Other Analgesics and Antipyretics</td><td colspan="1" rowspan="1">132</td></tr><tr><td colspan="1" rowspan="2">Anesthetics</td><td colspan="1" rowspan="1">Anesthetics, General</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Anethetics, Local</td><td colspan="1" rowspan="1">23</td></tr><tr><td colspan="1" rowspan="2">Antianemic Preparations</td><td colspan="1" rowspan="1">Iron Preparations</td><td colspan="1" rowspan="1">32</td></tr><tr><td colspan="1" rowspan="1">Vitamin B12 and Folic Acid</td><td colspan="1" rowspan="1">42</td></tr><tr><td colspan="1" rowspan="6">Antibacterials for Systemic Use</td><td colspan="1" rowspan="1">Beta-Lactam Antibacterials,Penicillins</td><td colspan="1" rowspan="1">13</td></tr><tr><td colspan="1" rowspan="1">Other Antibacterials</td><td colspan="1" rowspan="1">8</td></tr><tr><td colspan="1" rowspan="1">Other Beta-Lactam Antibacterials</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Quinolone Antibacterials</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">Sulfonamides</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Tetracyclines</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="2">Antibiotics and Chemotherapeuticsfor Determatological Use</td><td colspan="1" rowspan="1">Antibiotics for Topical Use</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Chemotherapeutics for Topical Use</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="5">Antidiarrheals, IntestinalInflammatory/Antiinfective Agents</td><td colspan="1" rowspan="1">Antidiarrheal Microorganisms</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Antipropulsives</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">Intestinal Adsorbents</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Intestinal Antiinflammatory Agents</td><td colspan="1" rowspan="1">35</td></tr><tr><td colspan="1" rowspan="1">Other Antidiarrheals</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Antiemetics and Antinauseants</td><td colspan="1" rowspan="1">Antiemetics and Antinauseants</td><td colspan="1" rowspan="1">19</td></tr><tr><td colspan="1" rowspan="1">Antiepileptics</td><td colspan="1" rowspan="1">Antiepileptics</td><td colspan="1" rowspan="1">110</td></tr><tr><td colspan="1" rowspan="2">Antifungals for Dermatologic Use</td><td colspan="1" rowspan="1">Antifungals for Systemic Use</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Antifungals for Topical Use</td><td colspan="1" rowspan="1">23</td></tr><tr><td colspan="1" rowspan="1">Antigout Preparations</td><td colspan="1" rowspan="1">Antigout Preparations</td><td colspan="1" rowspan="1">21</td></tr><tr><td colspan="1" rowspan="1">Antihistamines for Systemic Use</td><td colspan="1" rowspan="1">Antihistamines for Systemic Use</td><td colspan="1" rowspan="1">24</td></tr><tr><td colspan="1" rowspan="4">Antihypertensives</td><td colspan="1" rowspan="1">Antiadrenergic Agents, GenerallyActing</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Antiadrenergic Agents, PeripherallyActing</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Arteriolar Smooth Muscle, AgentsActing on</td><td colspan="1" rowspan="1">8</td></tr><tr><td colspan="1" rowspan="1">Other Antihypertensives</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Antiinflammatory andAntirheumatic Products</td><td colspan="1" rowspan="1">Antiinflammatory andAntirheumatic Products, Non-Steroids</td><td colspan="1" rowspan="1">34</td></tr><tr><td colspan="1" rowspan="1">Antimycotics for Systemic Use</td><td colspan="1" rowspan="1">Antimycotics for Systemic Use</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Antiobesity Preparations, Excl. DietProducts</td><td colspan="1" rowspan="1">Antiobesity Preparations, Excl. DietProducts</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="2">Anti-Parkinson Drugs</td><td colspan="1" rowspan="1">Anticholinergic Agents</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Dopaminergic Agents</td><td colspan="1" rowspan="1">16</td></tr><tr><td colspan="1" rowspan="2">Antiprotozoals</td><td colspan="1" rowspan="1">Agents Against Amoebiasis andOther Protozoal Diseases</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Antimalarials</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Antiseptics and Disinfectants</td><td colspan="1" rowspan="1">Antiseptics and Disinfectants</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Antithrombotic Agents</td><td colspan="1" rowspan="1">Antithrombotic Agents</td><td colspan="1" rowspan="1">237</td></tr><tr><td colspan="1" rowspan="1">Antivirals for Systemic use</td><td colspan="1" rowspan="1">Direct Acting Antivirals</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="2">Beta Blocking Agents</td><td colspan="1" rowspan="1">Beta Blocking Agents</td><td colspan="1" rowspan="1">147</td></tr><tr><td colspan="1" rowspan="1">Beta Blocking Agents and Thiazides</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Bile and Liver Therapy</td><td colspan="1" rowspan="1">Bile Therapy</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Blood Substitutes and PerfusionSolutions</td><td colspan="1" rowspan="1">Irrigating Solutions</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="2">Calcium Channel Blockers</td><td colspan="1" rowspan="1">Selective Calcium Channel Blockerswith Direct Cardiac Effects</td><td colspan="1" rowspan="1">16</td></tr><tr><td colspan="1" rowspan="1">Selective Calcium Channel Blockerswith Mainly Vascular Effects</td><td colspan="1" rowspan="1">64</td></tr><tr><td colspan="1" rowspan="1">Calcium Homeostasis</td><td colspan="1" rowspan="1">Anti-Parathyroid Agents</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Parathyroid Hormones andAnalogues</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="5">Cardiac Therapy</td><td colspan="1" rowspan="1">Antiarrhythmics, Class I and III</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Cardiac Glycosides</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Cardiac Stimulants, Excl. CardiacGlycosides</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Other Cardiac Preparations</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Vasodilators Used in CardiacDiseases</td><td colspan="1" rowspan="1">11</td></tr><tr><td colspan="1" rowspan="1">Corticosteroids for Systemic use</td><td colspan="1" rowspan="1">Corticosteroids for Systemic use,Plain</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Corticosteroids, DermatologicalPreparations</td><td colspan="1" rowspan="1">Corticosteroids, Plain</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="2">Cough and Cold Preparations</td><td colspan="1" rowspan="1">Cough Suppressants, Excl.Combinations with Expectorants</td><td colspan="1" rowspan="1">16</td></tr><tr><td colspan="1" rowspan="1">Expectorants, Excl. Combinationswith Cough Suppressants</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Digestives, Incl. Enzymes</td><td colspan="1" rowspan="1">Digestives, Incl. Enzymes</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="4">Diuretics</td><td colspan="1" rowspan="1">Aldosterone Antagonists and OtherPotassium-Sparing Agents</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">High-Ceiling Diuretics</td><td colspan="1" rowspan="1">53</td></tr><tr><td colspan="1" rowspan="1">Low-Ceiling Diuretics, Excl.Thiazides</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Low-Ceiling Diuretics, Thiazides</td><td colspan="1" rowspan="1">45</td></tr><tr><td colspan="1" rowspan="2">Drugs for Acid Related Disorders</td><td colspan="1" rowspan="1">Antacids</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease(GORD)</td><td colspan="1" rowspan="1">133</td></tr><tr><td colspan="1" rowspan="1">Drugs for Constipation</td><td colspan="1" rowspan="1">Drugs for Constipation</td><td colspan="1" rowspan="1">307</td></tr><tr><td colspan="1" rowspan="3">Drugs for FunctionalGastrointestinal Disorders</td><td colspan="1" rowspan="1">Belladonna and Derivatives, Plain</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Drugs for FunctionalGastrointestinal Disorders</td><td colspan="1" rowspan="1">21</td></tr><tr><td colspan="1" rowspan="1">Propulsives</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="3">Drugs for Obstructive AirwayDiseases</td><td colspan="1" rowspan="1">Adrenergics, Inhalants</td><td colspan="1" rowspan="1">53</td></tr><tr><td colspan="1" rowspan="1">Other Drugs for Obstructive AirwayDiseases, Inhalants</td><td colspan="1" rowspan="1">54</td></tr><tr><td colspan="1" rowspan="1">Other Systemic Drugs forObstructive Airway Diseases</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">Drugs for Treatment of BoneDiseases</td><td colspan="1" rowspan="1">Drugs Affecting Bone Structure andMineralization</td><td colspan="1" rowspan="1">12</td></tr><tr><td colspan="1" rowspan="1">Drugs Used in Diabetes</td><td colspan="1" rowspan="1">Blood Glucose Lowering Drugs,Excl. Insulins</td><td colspan="1" rowspan="1">359</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Insulins and Analogues</td><td colspan="1" rowspan="1">347</td></tr><tr><td colspan="1" rowspan="1">Ectoparasiticides, Incl. Scabicides,Insectides, and Repellents</td><td colspan="1" rowspan="1">Ectoparasiticides, Incl. Scabicides</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Emollients and Protectives</td><td colspan="1" rowspan="1">Emollients and Protectives</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="2">Endocrine Therapy</td><td colspan="1" rowspan="1">Hormone Antagonists and RelatedAgents</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Hormones and Related Agents</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Gynecological Antiinfectives andAntiseptics</td><td colspan="1" rowspan="1">Antiinfectives and Antiseptics, Excl.Combinations with Corticosteroids</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Immunosuppressants</td><td colspan="1" rowspan="1">Immunosuppressants</td><td colspan="1" rowspan="1">12</td></tr><tr><td colspan="1" rowspan="1">Lipid Modifying Agents</td><td colspan="1" rowspan="1">Lipid Modifying Agents, Plain</td><td colspan="1" rowspan="1">263</td></tr><tr><td colspan="1" rowspan="3">Mineral Supplements</td><td colspan="1" rowspan="1">Calcium</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Other Mineral Supplements</td><td colspan="1" rowspan="1">29</td></tr><tr><td colspan="1" rowspan="1">Potassium</td><td colspan="1" rowspan="1">24</td></tr><tr><td colspan="1" rowspan="1">Muscle Relaxants</td><td colspan="1" rowspan="1">Muscle Relaxants, Centrally ActingAgents</td><td colspan="1" rowspan="1">11</td></tr><tr><td colspan="1" rowspan="1">Nasal Preparations</td><td colspan="1" rowspan="1">Decongestants and Other NasalPreparations for Topical Use</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="6">Ophthalmologicals</td><td colspan="1" rowspan="1">Antiglaucoma Preparations andMiotics</td><td colspan="1" rowspan="1">51</td></tr><tr><td colspan="1" rowspan="1">Antiinfectives</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Antiinflammatory Agents</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Decongestants and Antiallergics</td><td colspan="1" rowspan="1">8</td></tr><tr><td colspan="1" rowspan="1">Ocular Vascular Disorder Agents</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Other Ophthalmologicals</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="2">Other Alimentary Tract andMetabolism Products</td><td colspan="1" rowspan="1">Other Alimentary Tract andMetabolism Products</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Other Mineral Supplements</td><td colspan="1" rowspan="1">29</td></tr><tr><td colspan="1" rowspan="1">Other Dermatological Preparations</td><td colspan="1" rowspan="1">Other Dermatological Preparations</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Other Drugs for Disorders of theMusculo-Skeletal System</td><td colspan="1" rowspan="1">Other Drugs for Disorders of theMusculo-Skeletal System</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="3">Other Nervous System Drugs</td><td colspan="1" rowspan="1">Drugs Used in Addictive Disorders</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Other Nervous System Drugs</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Parasympathomimetics</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Pituitary and HypothalamicHormones and Analogues</td><td colspan="1" rowspan="1">Posterior Pituitary Lobe Hormones</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Preparations for Treatment ofWounds and Ulcers</td><td colspan="1" rowspan="1">Cicatrizants</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="3">Psycholeptics</td><td colspan="1" rowspan="1">Antipsychotics</td><td colspan="1" rowspan="1">16</td></tr><tr><td colspan="1" rowspan="1">Anxiolytics</td><td colspan="1" rowspan="1">48</td></tr><tr><td colspan="1" rowspan="1">Hypnotics and Sedatives</td><td colspan="1" rowspan="1">58</td></tr><tr><td colspan="1" rowspan="2">Psychonaleptics</td><td colspan="1" rowspan="1">Anti-Dementia Drugs</td><td colspan="1" rowspan="1">12</td></tr><tr><td colspan="1" rowspan="1">Antidepressants</td><td colspan="1" rowspan="1">147</td></tr><tr><td colspan="1" rowspan="2"></td><td colspan="1" rowspan="1">Psycholeptics and Psychanaleptics inCombination</td><td colspan="1" rowspan="1">8</td></tr><tr><td colspan="1" rowspan="1">Psychostimulants, Agents Used forADHD and Nootropics</td><td colspan="1" rowspan="1">13</td></tr><tr><td colspan="1" rowspan="6">Sex Hormones and Modulators ofthe Genital System</td><td colspan="1" rowspan="1">Androgens</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Estrogens</td><td colspan="1" rowspan="1">13</td></tr><tr><td colspan="1" rowspan="1">Hormonal Contraceptives forSystemic Use</td><td colspan="1" rowspan="1">8</td></tr><tr><td colspan="1" rowspan="1">Other Sex Hormones andModulators fo the Genital System</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Progestogens</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Progestogens and Estrogens inCombination</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Stomatological Preparations</td><td colspan="1" rowspan="1">Stomatological Preparations</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Throat Preparations</td><td colspan="1" rowspan="1">Throat Preparations</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="2">Thyroid Therapy</td><td colspan="1" rowspan="1">Antithyroid Preparations</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Thyroid Preparations</td><td colspan="1" rowspan="1">96</td></tr><tr><td colspan="1" rowspan="1">Tonics</td><td colspan="1" rowspan="1">Other Mineral Supplements</td><td colspan="1" rowspan="1">29</td></tr><tr><td colspan="1" rowspan="1">Topical Products for Joint andMuscular Pain</td><td colspan="1" rowspan="1">Topical Products for Joint andMuscular Pain</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="2">Urologicals</td><td colspan="1" rowspan="1">Drugs Used in Benign ProstaticHypertrophy</td><td colspan="1" rowspan="1">40</td></tr><tr><td colspan="1" rowspan="1">Urologicals</td><td colspan="1" rowspan="1">18</td></tr><tr><td colspan="1" rowspan="2">Vasoprotectives</td><td colspan="1" rowspan="1">Agents for Treatment ofHemorrhoids and Anal Fissures forTopical Use</td><td colspan="1" rowspan="1">23</td></tr><tr><td colspan="1" rowspan="1">Capillary Stabilizing Agents</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="7">Vitamins</td><td colspan="1" rowspan="1">Ascorbic Acid (Vitamin C), Incl.Combinations</td><td colspan="1" rowspan="1">19</td></tr><tr><td colspan="1" rowspan="1">Calcium</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Multivitamins, Combinations</td><td colspan="1" rowspan="1">44</td></tr><tr><td colspan="1" rowspan="1">Other Plain Vitamin Preparations</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Vitamin A and D, Incl.Combinations of the Two</td><td colspan="1" rowspan="1">123</td></tr><tr><td colspan="1" rowspan="1">Vitamin B1, Plain and inCombination with Vitamin B6 andB12</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">Vitamin B-Complex, Incl.Combinations</td><td colspan="1" rowspan="1">1</td></tr></table>

An additional study was conducted to further assess the performance of the Assure Titanium Blood Glucose Monitoring System at the extreme upper and lower ends of the claimed measuring range. The sponsor altered 100 capillary whole blood samples from healthy donors, by spiking or allowing samples to glycolyze, to obtain 50 samples with glucose concentrations below $8 0 \mathrm { m g / d L }$ $ { 2 2 . 3 - 7 2 . 8 \mathrm { m g / d L } }$ , as measured by the comparator method) and 50 samples with glucose concentrations above $3 0 0 \mathrm { m g / d L }$ $( 3 0 3 . 5 { - } 5 7 7 . 3 \ \mathrm { m g / d L }$ , as measured by the comparator method).

Samples were tested on the Assure Titanium Blood Glucose Meter by intended use operators, using test strips from 3 lots and compared with the results obtained on the comparator method (YSI 2300 STAT Plus). The results are summarized below:

# Results for Glucose Concentrations $\mathbf { < 8 0 ~ m g / d L }$ :

Results for Glucose Concentrations $> 3 0 0 ~ \mathrm { m g / d L } ;$ :   

<table><tr><td rowspan=1 colspan=1>Within±5 mg/dL</td><td rowspan=1 colspan=1>Within±10 mg/dL</td><td rowspan=1 colspan=1>Within±12 mg/dL</td><td rowspan=1 colspan=1>Within±15 mg/dL</td></tr><tr><td rowspan=1 colspan=1>43/50(86%)</td><td rowspan=1 colspan=1>49/50(98%)</td><td rowspan=1 colspan=1>50/50(100%)</td><td rowspan=1 colspan=1>50/50(100%)</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Within±5 %</td><td rowspan=1 colspan=1>Within±10 %</td><td rowspan=1 colspan=1>Within±12 %</td><td rowspan=1 colspan=1>Within±15 %</td><td rowspan=1 colspan=1>Within±20 %</td></tr><tr><td rowspan=1 colspan=1>32/50(64%)</td><td rowspan=1 colspan=1>46/50(92%)</td><td rowspan=1 colspan=1>50/50(100%)</td><td rowspan=1 colspan=1>50/50(100%)</td><td rowspan=1 colspan=1>50/50(100%)</td></tr></table>

2. Matrix Comparison: Not applicable.

# C Clinical Studies:

1. Clinical Sensitivity: Not applicable.

2. Clinical Specificity: Not applicable.

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable): Not applicable.

# D Clinical Cut-Off:

Not applicable.

# E Expected Values/Reference Range:

Expected values for non-diabetics   
Expected blood glucose values for non-pregnant adults without diabetes1   
Fasting $^ { * } { < } 1 0 0 \ \mathrm { m g / d L }$   
2 hours after meals ${ < } 1 4 0 ~ \mathrm { m g / d L }$

\*Fasting is defined as no caloric intake for at least eight hours. Consult the patient's physician to determine the range that is appropriate for your patients.

1. American Diabetes Association. Standards of medical care in diabetes-2021. Diabetes Care.   
2021; 44(1); p.S17.

# F Other Supportive Instrument Performance Characteristics Data:

# 1. Hematocrit Study:

The effect of hematocrit on the performance of the Assure Titanium Blood Glucose Monitoring System was evaluated at $10 \%$ , $1 5 \%$ , $20 \%$ , $2 5 \%$ , $30 \%$ , $3 5 \%$ , $40 \%$ , $45 \%$ $50 \%$ , $5 5 \%$ , $60 \%$ , $65 \%$ and $70 \%$ hematocrit levels, and at 5 glucose concentrations (30-50, 51-110, 111-150, 151-250 and $2 5 1 { - } 4 0 0 \ \mathrm { m g / d L } )$ . Each sample was tested in replicates of 10 using 10 meters and 3 lots of test strips, for a total of 30 replicates per sample. The values were compared with the glucose measurements obtained from the comparator method (YSI 2300 STAT Plus). The results of the study demonstrated adequate performance to support the claimed hematocrit range of $10 \mathrm { - } 7 0 \%$ .

# 2. Altitude Study:

A simulated high-altitude study was conducted in a pressure chamber to simulate the effects of sea level $( < 5 0 0$ ft) and high-altitude (10,000 ft) on the Assure Titanium Blood Glucose Monitoring System. Venous whole blood samples adjusted to 3 glucose concentrations (55- 77, 114-144 and $3 1 6 { - } 3 5 6 ~ \mathrm { m g / d L }$ ) were tested in replicates of 10, using 10 meters and 3 lot of test strips, for a total of 30 replicates per sample, per condition. Values measured by the candidate device were compared with the glucose measurements obtained from the comparator method (YSI 2300 STAT Plus). The results of the study support the claim that the Assure Titanium Blood Glucose Monitoring System can be operated at altitudes of up to 10,000 ft (3,048 meters).

# 3. System Operating Conditions:

To assess the performance of the Assure Titanium Blood Glucose Monitoring System when used under various operating temperature and humidity conditions, the system was tested at four different temperature and humidity conditions including low temperature/low humidity $8 \%$ RH), low temperature/high humidity $8 \%$ RH), high temperature/low humidity $4 0 \ ^ { \circ } \mathrm { C } / 1 0 \%$ RH) and high temperature/high humidity $4 0 \ { } ^ { \circ } { \bf C } / 9 0 \%$ RH). Each of 3 venous whole blood glucose levels (55-77, 114-144 and $3 1 6 { - } 3 5 6 ~ \mathrm { m g / d L } )$ were tested by 10 meters, using 3 lots of test strips, for a total of 10 replicates per sample, per condition. Values measured by the Assure Titanium Blood Glucose Monitoring System were compared to the comparator method (YSI 2300 STAT Plus). The study results support the labeled operating conditions claim of $8 { - } 4 0 ^ { \circ } \mathrm { C }$ $( 4 6 { - } 1 0 4 ^ { \circ } \mathrm { F } )$ and $10 \mathrm { - } 9 0 \%$ RH.

4. Sample Volume Study:

The sponsor performed a study to support the claimed minimum sample volume of $0 . 5 \mu \mathrm { L }$ for the Assure Titanium Blood Glucose Monitoring System. Venous whole blood samples with 3 glucose concentrations (50-65, 100-120 and $2 0 0 { - } 2 5 0 \ \mathrm { m g / d L }$ ) were tested at 6 sample volumes (0.1, 0.3, 0.5, 1.0 and 5.0 and $1 0 . 0 \mu \mathrm { L }$ using 3 lots of test strips. Values obtained were compared to the comparator method (YSI 2300 STAT Plus). Results support the claimed minimum sample volume of $0 . 5 \mu \mathrm { L }$ for the system. The meter has an error message displayed if enough blood is not added to the test strip. This feature was validated and was shown to function as intended.

# 5. Flex Studies:

Intermittent sampling, sample perturbation, testing with used test strips and a variety of mechanical/durability testing (i.e., drop, vibration and compression testing) was completed by the sponsor. The testing performed demonstrated that the Assure Titanium Blood Glucose Monitoring System is robust to these expected use scenarios.

6. Cleaning and Disinfection Robustness Evaluation:

The device is intended for multiple-patient use. Disinfection efficacy studies were performed on the on the exterior meter materials by an outside commercial testing laboratory, demonstrating complete inactivation of Hepatitis B Virus (HBV) with the chosen disinfectant, Super Sani-Cloth Germicidal Disposable Wipe (EPA Registration Number 9480-4). Robustness studies were also performed by the sponsor demonstrating that there was no change in performance or external materials of the meter after 10,950 cycles of cleaning and disinfection using the chosen disinfectant. The robustness studies were designed to simulate cleaning and disinfection over the 3-year multi-patient use life of the meter. Labeling was reviewed for adequate instructions for the validated cleaning and disinfection procedures.

# 7. Electromagnetic Compatibility and Electrical Safety:

The sponsor provided documentation certifying that acceptable electrical safety and electromagnetic compatibility (EMC) testing had been performed and the system was found to be compliant.

# 8. Test Strip Lot Release Protocol:

The test strip lot release protocol and acceptance criteria were reviewed and found to be acceptable.

# VIII Proposed Labeling:

The labeling supports the finding of substantial equivalence for this device.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.